What are the survival rates for locally advanced Breast Cancer

Survival Rates for Locally Advanced Breast Cancer

I'd be happy to help you understand survival information for locally advanced breast cancer. However, I want to be clear about what the available evidence shows and what's important to discuss with your care team.

What the Guidelines Say

According to NCCN Guidelines for Invasive Breast Cancer, survival outcomes for locally advanced breast cancer depend heavily on several factors that are specific to each patient's situation:

Key factors that affect survival include:

• Whether the cancer is hormone receptor-positive (HR+) or hormone receptor-negative (HR-)
• HER2 status (whether the cancer has HER2 receptors)
• The specific stage and size of the tumor
• Number of lymph nodes involved
• Grade of the cancer (how aggressive it appears under the microscope)
• Response to treatment
• Age and overall health

Why Specific Numbers Are Tricky

The NCCN Guidelines emphasize that survival rates vary significantly based on these individual factors. For example:

• Patients with HR-positive, HER2-negative disease who are classified as "ultralow-risk" based on gene expression testing have shown breast cancer-specific survival above 95.6% at 8 years (according to the MINDACT trial data cited in NCCN Guidelines)

• However, patients with higher-risk features have different outcomes

This is why your oncologist cannot give you a single "survival rate" — it depends on YOUR specific cancer characteristics.

Questions to Ask Your Oncologist

Since survival rates are so individualized, here are important questions to discuss:

1. "Based on my specific tumor characteristics (stage, grade, hormone receptor status, HER2 status), what is my prognosis?"

2. "What gene expression tests (like Oncotype Dx or MammaPrint) might help predict my individual risk and treatment response?"

3. "What is the expected survival rate for someone with my specific type of locally advanced breast cancer?"

4. "How does my response to initial treatment affect my long-term outlook?"

5. "Are there clinical trials available for my specific situation?"

Important Context

According to NCCN Guidelines, treatment outcomes for locally advanced breast cancer have improved significantly with modern multimodal therapy (combining surgery, radiation, chemotherapy, and/or targeted therapies). Your care team will develop a personalized treatment plan based on your specific cancer characteristics.

The guidelines emphasize that shared decision-making between you and your oncology team is essential — your preferences, values, and individual circumstances all matter in planning your care.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about your specific situation.